https://www.biopharmaapac.com/news/78/4650/actinogen-medical-launches-phase-2b-xanamia-trial-for-alzheimers-marks-first-patient-treatment.html
Actinogen Medical Launches Phase 2b XanaMIA Trial for Alzheimer's, Marks First Patient Treatment
Actinogen Medical Launches Phase 2b XanaMIA Trial for Alzheimer's, Marks First Patient Treatment
actinogen medicals markslaunchesphasetrial
https://biotechdispatch.com.au/news/actinogen-medical-closes-10-million-rights-issue-offer
Actinogen Medical closes $10 million rights issue offer - Biotech
The company said the funds raised will be used to progress its Phase 2 clinical trial program, including completion of the XanaCIDD trial of Xanamem in...
actinogen medicalrights issueclosesmillionoffer